Rapport Therapeutics, Inc. · NASDAQ:RAPP

Third Rock Ventures V, L.P. reported a 19.50% stake in Rapport Therapeutics, Inc. (Schedule 13G)

Event Dec 31, 2024 · Filed Feb 13, 2025

Third Rock Ventures V, L.P. reported a 19.50% stake in Rapport Therapeutics, Inc., 7,135,233 shares, as a passive investor on Dec 31, 2024. Filed Feb 13, 2025 (Schedule 13G).

Stake
19.50%
Shares
7,135,233
Intent
Passive
What changed
Crossed above 5%
Filed together
6 holders

The filing in full

HolderStakeShares
Third Rock Ventures V, L.P.19.50%7,135,233
Third Rock Ventures GP V, L.P.19.50%7,135,233
TRV GP V, LLC19.50%7,135,233
Third Rock Ventures VI, L.P.2.70%969,218
Third Rock Ventures GP VI, L.P.2.70%969,218
TRV GP VI, LLC2.70%969,218

Source

View original at SEC

Related